UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007268
Receipt number R000008574
Scientific Title Prophylaxis of Tetanus by Quick Test study
Date of disclosure of the study information 2012/02/14
Last modified on 2014/05/09 16:15:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prophylaxis of Tetanus by Quick Test study

Acronym

Proteqt study

Scientific Title

Prophylaxis of Tetanus by Quick Test study

Scientific Title:Acronym

Proteqt study

Region

Japan


Condition

Condition

trauma patients

Classification by specialty

Surgery in general Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to validate the efficacy of the Tetanus Quick Stick (TQS) for tetanus antibody and establish a system based on epidemiological survey of tetanus prophylaxis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The primary outcome is to compare the sensitivity and the specificity of Tetanus Quick Stick (TQS) for tetanus antibody with them of Particle Agglutination method .

Key secondary outcomes

The secondry outcome is survey patients with tetanus antibody epidemiology.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

90 months-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Trauma pacients admitted in the emergency room while the laboratory is available.
The sample is used by drawing blood to other purpose.

Key exclusion criteria

Not agreement of this study

Target sample size

2200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryo Sasaki

Organization

National Center for Global Health and Medicine

Division name

Department of Emergency medicine and Critical care

Zip code


Address

1-21-1, Toyama, Shinjyuku-ku, Tokyo, Japan

TEL

03-3202-7181

Email

rysasaki@hosp.ncgm.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ryo Sasaki

Organization

National Center for Global Health and Medicine

Division name

Department of Emergency medicine and Critical care

Zip code


Address

1-21-1, Toyama, Shinjyuku-ku, Tokyo, Japan

TEL

03-3202-7181

Homepage URL


Email

rysasaki@hosp.ncgm.go.jp


Sponsor or person

Institute

National Center for Global Health and Medicine

Institute

Department

Personal name



Funding Source

Organization

Bureau of International Cooperation

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

独立行政法人国立国際医療研究センター(東京都)
新潟市民病院(新潟県)
独立行政法人国立病院機構水戸医療センター(茨城県)
兵庫県立淡路病院(兵庫県)
順天堂大学医学部付属浦安病院(千葉県)
福山市民病院(広島県)
長崎大学病院(長崎県)
島根大学医学部付属病院(島根県)


Other administrative information

Date of disclosure of the study information

2012 Year 02 Month 14 Day


Related information

URL releasing protocol

http://www.jast-hp.org/syourai/hasyofu.html

Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 02 Month 07 Day

Date of IRB


Anticipated trial start date

2012 Year 03 Month 01 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 03 Month 31 Day

Date trial data considered complete

2015 Year 04 Month 30 Day

Date analysis concluded

2015 Year 06 Month 30 Day


Other

Other related information

The subject is trauma pacients admitted in emergency room while the laboratory is available.
The sample is used by drawing blood to other purpose.
The meterial and methods are 1) to measure the tetanus antibodies on Tetanus Quick Stick (TQS) and Particle Agglutination method from the sample of the pacients, 2) and examine the occurance of tetanus about 21 days after the injury.


Management information

Registered date

2012 Year 02 Month 11 Day

Last modified on

2014 Year 05 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008574


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name